Indapamide
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| FADB-China ID | C0547 |
| Substance Name | Diuretics |
| Substance Chinese Name | 利尿剂 |
| Molecular Name | Indapamide |
| Molecular Chinese Name | 吲达帕胺 |
| 2D Structure | |
| CAS Number | 26807-65-8 |
| PubChem CID | 3702 |
| Formula | C16H16ClN3O3S |
| IUPAC Name | 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide |
| InChI Key | NDDAHWYSQHTHNT-UHFFFAOYSA-N |
| InChI | InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23) |
| Canonical SMILES | CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N |
| Isomeric SMILES | CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N |
| CFM-ID 3.0 | URL Link |
| Related links | Processing |
| Addition Purposes | Enhance health care function |
| Molecular Synonyms |
Indapamide
26807-65-8
Noranat
Tertensif
Veroxil
Lozol
Indaflex
Arifon
Indamol
Fludex
|
| Data Uploader | Shuyu Ouyang |
| Update Date | Jul 25, 2019 20:46 |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 365.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Complexity | 580 |
| Monoisotopic Mass | 365.0600903 |
| Exact Mass | 365.0600903 |
| XLogP | 2.9 |
| Formal Charge | 0 |
| Heavy Atom Count | 24 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.8868 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.5529 |
| P-glycoprotein Substrate | Non-substrate | 0.6859 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9158 |
| Non-inhibitor | 0.9179 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8575 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4101 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.5265 |
| CYP450 2D6 Substrate | Non-substrate | 0.7924 |
| CYP450 3A4 Substrate | Non-substrate | 0.5190 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5820 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5775 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8151 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6572 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7471 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9860 |
| Non-inhibitor | 0.8804 | |
| AMES Toxicity | Non AMES toxic | 0.6869 |
| Carcinogens | Non-carcinogens | 0.7674 |
| Fish Toxicity | High FHMT | 0.9912 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8758 |
| Honey Bee Toxicity | Low HBT | 0.8572 |
| Biodegradation | Not ready biodegradable | 0.9862 |
| Acute Oral Toxicity | III | 0.7853 |
| Carcinogenicity (Three-class) | Non-required | 0.6473 |
ADMET -- Regression
| Model | Value | Unit |
|---|---|---|
| Aqueous solubility | -3.5275 | LogS |
| Caco-2 Permeability | 1.1615 | LogPapp, cm/s |
| Rat Acute Toxicity | 2.0823 | LD50, mol/kg |
| Fish Toxicity | 1.6744 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.4193 | pIGC50, ug/L |
Related Foods
| FADB-China ID | F0142 |
| Food Image | ![]() |
| Food Name | Plant food supplements |
| Food Chinese Name | 植物食品补充剂 |
| Food Type | Processed food |
| References | Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review |
References
| Title | DOI/PubMed/ISSN |
|---|---|
| Simultaneous Determination of 10 Adulterants in Antihypertensive Functional Foods Using Multi-Walled Carbon Nanotubes-Dispersive Solid-Phase Extraction Coupled with High Performance Liquid Chromatography. | 25840433 |
| Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review |
